Compare FTRE & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTRE | CMP |
|---|---|---|
| Founded | 1996 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 864.4M | 781.2M |
| IPO Year | N/A | 2003 |
| Metric | FTRE | CMP |
|---|---|---|
| Price | $14.93 | $17.07 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $11.64 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 1.3M | 447.2K |
| Earning Date | 11-05-2025 | 12-08-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,759,900,000.00 | $1,225,200,000.00 |
| Revenue This Year | $3.17 | $12.05 |
| Revenue Next Year | $0.04 | $4.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 1.88 | ★ 7.27 |
| 52 Week Low | $3.97 | $8.60 |
| 52 Week High | $23.22 | $22.69 |
| Indicator | FTRE | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 69.87 | 42.32 |
| Support Level | $14.06 | $18.56 |
| Resistance Level | $14.96 | $21.43 |
| Average True Range (ATR) | 1.02 | 1.02 |
| MACD | 0.26 | -0.02 |
| Stochastic Oscillator | 98.26 | 13.38 |
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.